Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

Patients with COPD and heart failure treated with SGLT-2 inhibitors experienced higher rates of volume depletion and adverse renal events. Chronic obstructive pulmonary disease (COPD) reduces the ...

You did it to yourself.” This is one of the things that patients who are diagnosed with COPD often hear because of the stigma ...

In 2022, after a year of mental health issues spurred by a life-threatening pulmonary embolism, I decided to sell the ...

March 20, 2026. More for You ...

The ACQ-5 identifies overt airflow limitation but not isolated small airway dysfunction in treatment-naïve uncontrolled asthma.

CHEST and its Women in Chest Medicine interest group helped Ghada Bourjeily, MD, transform the management of sleep issues ...

The 2026 IASLC Targeted Therapies in Lung Cancer meeting brought together leading oncologists, surgeons, and patient ...

COPD breathlessness action plans may help patients manage episodes, reduce anxiety, and avoid emergency care. Read more.

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz ® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the ...

American College of Cardiology (ACC), and nine other leading medical organizations have released updated guidelines for ...